ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,192, issued on Dec. 9, was assigned to YS LIFE SCIENCE Co. LTD. (Seoul, South Korea).
"Crystalline form of lifitegrast, and pharmaceutical composition comprising the same" was invented by Eunim Jeong (Suwon-si, South Korea), Areum Baek (Suwon-si, South Korea) and Hyunik Shin (Suwon-si, South Korea).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a novel crystalline form of lifitegrast and a pharmaceutical composition containing the novel crystalline form of lifitegrast. The crystalline form of lifitegrast has improved solubility and excellent stability against heat and moisture, thereby being effectively used for preparing a pharmaceutical ...